Published on: 10 August 2020 FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and older more
Published on: 10 August 2020 Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis more
